Human Cell Biology ELISA Kits 5
Human PON1 (Paraoxonase 1) CLIA Kit (HUES01194)
- SKU:
- HUES01194
- Product Type:
- ELISA Kit
- ELISA Type:
- CLIA Kit
- Size:
- 96 Assays
- Sensitivity:
- 18.75pg/mL
- Range:
- 31.25-2000pg/mL
- ELISA Type:
- Sandwich
- Reactivity:
- Human
- Sample Type:
- Serum, plasma and other biological fluids
- Research Area:
- Cell Biology
Description
Assay type: | Sandwich |
Format: | 96T |
Assay time: | 4.5h |
Reactivity: | Human |
Detection method: | Chemiluminescence |
Detection range: | 31.25-2000 pg/mL |
Sensitivity: | 18.75 pg/mL |
Sample volume: | 100µL |
Sample type: | Serum, plasma and other biological fluids |
Repeatability: | CV < 15% |
Specificity: | This kit recognizes Human PON1 in samples. No significant cross-reactivity or interference between Human PON1 and analogues was observed. |
This kit uses Sandwich-CLIA as the method. The micro CLIA plate provided in this kit has been pre-coated with an antibody specific to Human PON1. Standards or samples are added to the appropriate micro CLIA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human PON1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well successively and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human PON1, biotinylated detection antibody and Avidin-HRP conjugate will appear fluorescence. The Relative light unit (RLU) value is measured spectrophotometrically by the Chemiluminescence immunoassay analyzer. The RLU value is positively associated with the concentration of Human PON1. The concentration of Human PON1 in the samples can be calculated by comparing the RLU of the samples to the standard curve.
UniProt Protein Function: | PON1: Hydrolyzes the toxic metabolites of a variety of organophosphorus insecticides. Capable of hydrolyzing a broad spectrum of organophosphate substrates and lactones, and a number of aromatic carboxylic acid esters. Mediates an enzymatic protection of low density lipoproteins against oxidative modification and the consequent series of events leading to atheroma formation. Genetic variation in PON1 is associated with susceptibility to microvascular complications of diabetes type 5 (MVCD5). These are pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new- onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis. Homozygosity for the Leu-54 allele is strongly associated with the development of retinal disease in diabetic patients. Belongs to the paraoxonase family. |
UniProt Protein Details: | Protein type:Lipid-binding; EC 3. 1. 8. 1; EC 3. 1. 1. 2; Secreted, signal peptide; Hydrolase; Secreted; Phosphatase (non-protein); Motility/polarity/chemotaxis; EC 3. 1. 1. 81 Chromosomal Location of Human Ortholog: 7q21. 3 Cellular Component: extracellular space; intracellular membrane-bound organelle; extracellular region Molecular Function:protein homodimerization activity; arylesterase activity; phospholipid binding; calcium ion binding; aryldialkylphosphatase activity Biological Process: response to nutrient levels; response to external stimulus; dephosphorylation; organophosphate catabolic process; response to toxin; positive regulation of transporter activity; carboxylic acid catabolic process; positive regulation of binding; aromatic compound catabolic process; phosphatidylcholine metabolic process Disease: Microvascular Complications Of Diabetes, Susceptibility To, 5 |
NCBI Summary: | The enzyme encoded by this gene is an arylesterase that mainly hydrolyzes paroxon to produce p-nitrophenol. Paroxon is an organophosphorus anticholinesterase compound that is produced in vivo by oxidation of the insecticide parathion. Polymorphisms in this gene are a risk factor in coronary artery disease. The gene is found in a cluster of three related paraoxonase genes at 7q21. 3. [provided by RefSeq, Oct 2008] |
UniProt Code: | P27169 |
NCBI GenInfo Identifier: | 308153572 |
NCBI Gene ID: | 5444 |
NCBI Accession: | P27169. 3 |
UniProt Secondary Accession: | P27169,Q16052, Q6B0J6, Q9UCB1, B2RA40, |
UniProt Related Accession: | P27169 |
Molecular Weight: | 39,731 Da |
NCBI Full Name: | Serum paraoxonase/arylesterase 1 |
NCBI Synonym Full Names: | paraoxonase 1 |
NCBI Official Symbol: | PON1 |
NCBI Official Synonym Symbols: | ESA; PON; MVCD5 |
NCBI Protein Information: | serum paraoxonase/arylesterase 1; K-45; PON 1; esterase A; A-esterase 1; paraoxonase B-type; aromatic esterase 1; arylesterase B-type; serum aryldiakylphosphatase; serum aryldialkylphosphatase 1 |
UniProt Protein Name: | Serum paraoxonase/arylesterase 1 |
UniProt Synonym Protein Names: | Aromatic esterase 1; A-esterase 1; K-45; Serum aryldialkylphosphatase 1 |
Protein Family: | Serum paraoxonase/arylesterase |
UniProt Gene Name: | PON1 |
UniProt Entry Name: | PON1_HUMAN |
As the RLU values of the standard curve may vary according to the conditions of the actual assay performance (e. g. operator, pipetting technique, washing technique or temperature effects), the operator should establish a standard curve for each test. Typical standard curve and data is provided below for reference only.
Concentration (pg/mL) | RLU | Average | Corrected |
2000 | 52127 59315 | 55721 | 55693 |
1000 | 22238 25710 | 23974 | 23946 |
500 | 11205 10859 | 11032 | 11004 |
250 | 4976 5612 | 5294 | 5266 |
125 | 2758 2458 | 2608 | 2580 |
62.5 | 1391 1231 | 1311 | 1283 |
31.25 | 668 680 | 674 | 646 |
0 | 27 29 | 28 | -- |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, mid range and high level Human PON1 were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, mid range and high level Human PON1 were tested on 3 different plates, 20 replicates in each plate.
Intra-assay Precision | Inter-assay Precision | |||||
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (pg/mL) | 101.79 | 198.63 | 730.05 | 108.67 | 207.99 | 757.05 |
Standard deviation | 8.54 | 22.45 | 52.05 | 12.40 | 24.15 | 70.48 |
C V (%) | 8.39 | 11.30 | 7.13 | 11.41 | 11.61 | 9.31 |
Recovery
The recovery of Human PON1 spiked at three different levels in samples throughout the range of the assay was evaluated in various matrices.
Sample Type | Range (%) | Average Recovery (%) |
Serum (n=5) | 99-114 | 107 |
EDTA plasma (n=5) | 84-98 | 91 |
Cell culture media (n=5) | 95-107 | 101 |
Linearity
Samples were spiked with high concentrations of Human PON1 and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.
Serum (n=5) | EDTA plasma (n=5) | Cell culture media (n=5) | ||
1:2 | Range (%) | 98-113 | 102-116 | 98-113 |
Average (%) | 104 | 108 | 104 | |
1:4 | Range (%) | 98-113 | 94-105 | 86-101 |
Average (%) | 104 | 99 | 93 | |
1:8 | Range (%) | 102-114 | 87-103 | 95-110 |
Average (%) | 108 | 95 | 102 | |
1:16 | Range (%) | 97-110 | 101-115 | 95-108 |
Average (%) | 103 | 107 | 102 |
An unopened kit can be stored at 4°C for 1 month. If the kit is not used within 1 month, store the items separately according to the following conditions once the kit is received.
Item | Specifications | Storage |
Micro CLIA Plate(Dismountable) | 8 wells ×12 strips | -20°C, 6 months |
Reference Standard | 2 vials | |
Concentrated Biotinylated Detection Ab (100×) | 1 vial, 120 µL | |
Concentrated HRP Conjugate (100×) | 1 vial, 120 µL | -20°C(shading light), 6 months |
Reference Standard & Sample Diluent | 1 vial, 20 mL | 4°C, 6 months |
Biotinylated Detection Ab Diluent | 1 vial, 14 mL | |
HRP Conjugate Diluent | 1 vial, 14 mL | |
Concentrated Wash Buffer (25×) | 1 vial, 30 mL | |
Substrate Reagent A | 1 vial, 5 mL | 4°C (shading light) |
Substrate Reagent B | 1 vial, 5 mL | 4°C (shading light) |
Plate Sealer | 5 pieces | |
Product Description | 1 copy | |
Certificate of Analysis | 1 copy |
- Set standard, test sample and control (zero) wells on the pre-coated plate and record theirpositions. It is recommended to measure each standard and sample in duplicate. Note: addall solutions to the bottom of the plate wells while avoiding contact with the well walls. Ensuresolutions do not foam when adding to the wells.
- Aliquot 100 µL of standard solutions into the standard wells.
- Add 100 µL of Sample / Standard dilution buffer into the control (zero) well.
- Add 100 µL of properly diluted sample (serum, plasma, tissue homogenates and otherbiological fluids. ) into test sample wells.
- Cover the plate with the sealer provided in the kit and incubate for 90 min at 37 °C.
- Aspirate the liquid from each well, do not wash. Immediately add 100 µL of BiotinylatedDetection Ab working solution to each well. Cover the plate with a plate seal and gently mix. Incubate for 1 hour at 37 °C.
- Aspirate or decant the solution from the plate and add 350 µL of wash buffer to each welland incubate for 1-2 minutes at room temperature. Aspirate the solution from each well andclap the plate on absorbent filter paper to dry. Repeat this process 3 times. Note: a microplatewasher can be used in this step and other wash steps.
- Add 100 µL of HRP Conjugate working solution to each well. Cover with a plate seal andincubate for 30 min at 37 °C.
- Aspirate or decant the solution from each well. Repeat the wash process for five times asconducted in step 7.
- Add 100 µL of Substrate mixture solution to each well. Cover with a new plate seal andincubate for no more than 5 min at 37 °C. Protect the plate from light.
- Determine the RLU value of each well immediately.